Illumina, Inc. (ILMN)
209.55
-3.38
(-1.59%)
USD |
NASDAQ |
Nov 12, 16:00
209.60
+0.05
(+0.02%)
Pre-Market: 08:07
Illumina Price : 209.55 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 204.41 | 211.75 | 197.81 | 209.55 | 1.727M |
| Nov 11, 2026 | 219.97 | 227.71 | 212.74 | 212.93 | 1.865M |
| Nov 10, 2026 | 217.76 | 220.83 | 212.00 | 214.91 | 1.363M |
| Nov 09, 2026 | 216.98 | 222.85 | 211.21 | 220.78 | 1.864M |
| Nov 06, 2026 | 208.52 | 216.00 | 205.51 | 213.13 | 2.065M |
| Nov 05, 2026 | 220.25 | 221.48 | 205.00 | 208.00 | 4.237M |
| Nov 04, 2026 | 241.00 | 244.05 | 224.05 | 226.54 | 3.036M |
| Nov 03, 2026 | 233.14 | 241.85 | 229.08 | 238.21 | 2.232M |
| Nov 02, 2026 | 236.01 | 236.01 | 223.33 | 226.58 | 2.926M |
| Oct 30, 2026 | 255.76 | 256.09 | 231.18 | 235.99 | 5.390M |
| Oct 29, 2026 | 286.05 | 293.17 | 283.00 | 290.06 | 2.035M |
| Oct 28, 2026 | 278.04 | 294.20 | 277.20 | 288.79 | 2.239M |
| Oct 27, 2026 | 269.42 | 282.18 | 266.20 | 279.47 | 1.783M |
| Oct 26, 2026 | 269.69 | 274.00 | 267.29 | 271.04 | 1.330M |
| Oct 23, 2026 | 264.42 | 271.64 | 264.42 | 269.42 | 1.263M |
| Oct 22, 2026 | 281.42 | 283.55 | 257.31 | 269.40 | 2.224M |
| Oct 21, 2026 | 267.35 | 286.40 | 263.28 | 282.86 | 2.272M |
| Oct 20, 2026 | 264.13 | 271.43 | 260.15 | 267.93 | 1.585M |
| Oct 19, 2026 | 268.93 | 270.94 | 260.24 | 262.66 | 1.903M |
| Oct 16, 2026 | 267.49 | 272.00 | 259.26 | 262.54 | 2.490M |
| Oct 15, 2026 | 267.24 | 275.49 | 257.14 | 267.93 | 2.989M |
| Oct 14, 2026 | 269.19 | 276.55 | 267.23 | 271.76 | 2.121M |
| Oct 13, 2026 | 276.58 | 276.85 | 267.27 | 271.18 | 1.894M |
| Oct 12, 2026 | 277.60 | 278.00 | 268.52 | 276.67 | 1.643M |
| Oct 09, 2026 | 268.21 | 278.59 | 265.25 | 278.17 | 1.896M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agilent Technologies, Inc. | 173.01 |
| Thermo Fisher Scientific, Inc. | 699.44 |
| QIAGEN NV | 50.10 |
| Pacific Biosciences of California, Inc. | 1.97 |
| Bio-Rad Laboratories, Inc. | 370.48 |
Price Related Metrics
| PE Ratio | 36.00 |
| PS Ratio | 7.093 |
| PEG Ratio | 1.184 |
| Price to Book Value | 10.13 |
| Price to Free Cash Flow | 50.58 |
| Earnings Yield | 2.78% |
| Market Cap | 31.85B |
| PEGY Ratio | 1.184 |
| Operating PE Ratio | 34.24 |
| Normalized PE Ratio | 41.15 |